WEED, Inc.
$0.03-0.99%($-0.00)
TickerSpark Score
39/100
60
Valuation
40
Profitability
15
Growth
32
Health
50
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BUDZ research report →
52-Week Range17% of range
Low $0.02
Current $0.03
High $0.08
Companyweedincusa.com
WEED, Inc. , together with its subsidiaries, focuses on the development and application of cannabis-derived compounds for the treatment of human diseases. The company was formerly known as United Mines, Inc.
- CEO
- Glenn E. Martin
- IPO
- 2010
- Employees
- 2
- HQ
- Tucson, AZ, US
Price Chart
-2.56% · this period
Valuation
- Market Cap
- $4.45M
- P/E
- -4.00
- P/S
- 0.00
- P/B
- -5.28
- EV/EBITDA
- -4.82
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 177.63%
- ROIC
- 350.83%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-1,372,206 · -168.68%
- EPS
- $-0.01 · -143.90%
- Op Income
- $-1,327,679
- FCF YoY
- 53.04%
Performance & Tape
- 52W High
- $0.08
- 52W Low
- $0.02
- 50D MA
- $0.03
- 200D MA
- $0.04
- Beta
- 1.42
- Avg Volume
- 59.42K
Get TickerSpark's AI analysis on BUDZ
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jan 22, 26 | BREEN NICOLE M | sell | 38,000 |
| Feb 2, 26 | BREEN NICOLE M | sell | 31,625 |
| Feb 3, 26 | BREEN NICOLE M | sell | 40,000 |
| Feb 4, 26 | BREEN NICOLE M | sell | 58,980 |
| Feb 11, 26 | BREEN NICOLE M | sell | 37,000 |
| Feb 12, 26 | BREEN NICOLE M | sell | 35,000 |
| May 6, 22 | BREEN NICOLE M | sell | 30,000 |
| Apr 26, 22 | BREEN NICOLE M | sell | 20,000 |
| Apr 18, 22 | BREEN NICOLE M | sell | 35,000 |
| Mar 28, 22 | BREEN NICOLE M | sell | 20,000 |
Our BUDZ Coverage
We haven't published any research on BUDZ yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate BUDZ Report →Similar Companies
PCLOF-33.75%
PharmaCielo Ltd.
$0.05
CVSI+2.74%
CV Sciences, Inc.
$0.03
VDQSF+733.33%
Gnomestar Craft Inc.
$0.01
THCBF+0.00%
THC Biomed Intl Ltd.
$0.00
AUSAF+0.00%
Australis Capital Inc.
$0.00
CBIH+20.00%
Cannabis Bioscience International Holdings, Inc.
$0.00
BBRRF+1.64%
Blueberries Medical Corp.
$0.01
IONKF+0.00%
Ionic Brands Corp.
$0.00